Literature DB >> 28985211

Rationalizing combination therapies.

.   

Abstract

Mesh：

Year:  2017        PMID： 28985211     DOI： 10.1038/nm.4426

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

1.  Development of novel combination therapies.

Authors:  Janet Woodcock; Joseph P Griffin; Rachel E Behrman
Journal:  N Engl J Med       Date:  2011-02-16       Impact factor: 91.245

Review 2.  CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition.

Authors:  Elizabeth I Buchbinder; Anupam Desai
Journal:  Am J Clin Oncol       Date:  2016-02       Impact factor: 2.339
  2 in total
  18 in total

1.  A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.

Authors:  Adam C Palmer; Christopher Chidley; Peter K Sorger
Journal:  Elife       Date:  2019-11-19       Impact factor: 8.140

2.  Demonstrating Contribution of Components of Fixed-Dose Drug Combinations Through Longitudinal Exposure-Response Analysis.

Authors:  Asbjørn Nøhr-Nielsen; Theis Lange; Julie Lyng Forman; Theodoros Papathanasiou; David J R Foster; Richard N Upton; Ole Jannik Bjerrum; Trine Meldgaard Lund
Journal:  AAPS J       Date:  2020-01-27       Impact factor: 4.009

3.  Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry.

Authors:  Xiyuan Lu; G Lavender Hackman; Achinto Saha; Atul Singh Rathore; Meghan Collins; Chelsea Friedman; S Stephen Yi; Fumio Matsuda; John DiGiovanni; Alessia Lodi; Stefano Tiziani
Journal:  iScience       Date:  2022-04-07

Review 4.  Independent Drug Action in Combination Therapy: Implications for Precision Oncology.

Authors:  Deborah Plana; Adam C Palmer; Peter K Sorger
Journal:  Cancer Discov       Date:  2022-03-01       Impact factor: 38.272

5.  Biophysical Modeling Suggests Optimal Drug Combinations for Improving the Efficacy of GABA Agonists after Traumatic Brain Injuries.

Authors:  Shyam Kumar Sudhakar; Thomas J Choi; Omar J Ahmed
Journal:  J Neurotrauma       Date:  2019-01-08       Impact factor: 5.269

Review 6.  Supramolecular metal-based nanoparticles for drug delivery and cancer therapy.

Authors:  Xiaomin Jiang; Chunbai He; Wenbin Lin
Journal:  Curr Opin Chem Biol       Date:  2021-02-22       Impact factor: 8.822

7.  Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice.

Authors:  Katarzyna Załuska-Ogryzek; Paweł Marzęda; Paula Wróblewska-Łuczka; Magdalena Florek-Łuszczki; Zbigniew Plewa; Hubert Bojar; Dorota Zolkowska; Jarogniew J Łuszczki
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

Review 8.  Systematic review of combinations of targeted or immunotherapy in advanced solid tumors.

Authors:  Aaron C Tan; Stephen J Bagley; Patrick Y Wen; Michael Lim; Michael Platten; Howard Colman; David M Ashley; Wolfgang Wick; Susan M Chang; Evanthia Galanis; Alireza Mansouri; Simon Khagi; Minesh P Mehta; Amy B Heimberger; Vinay K Puduvalli; David A Reardon; Solmaz Sahebjam; John Simes; Scott J Antonia; Don Berry; Mustafa Khasraw
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

Review 9.  Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier.

Authors:  Jia Li; Meng Zheng; Olga Shimoni; William A Banks; Ashley I Bush; Jennifer R Gamble; Bingyang Shi
Journal:  Adv Sci (Weinh)       Date:  2021-06-03       Impact factor: 16.806

10.  Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cells.

Authors:  Zhangfeng Zhong; Haibing Yu; Shengpeng Wang; Yitao Wang; Liao Cui
Journal:  Chin Med       Date:  2018-08-29       Impact factor: 5.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.